
Wilms Tumor Protein Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281601
Publisher: Date of Publish:
No. of Pages: 77 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
This report contains market size and forecasts of Wilms Tumor Protein in global, including the following market information: Global Wilms Tumor Protein Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Wilms Tumor Protein Market Sales, 2017-2022, 2023-2028, (K Pcs) Global top five Wilms Tumor Protein companies in 2021 (%) The global Wilms Tumor Protein market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Elatipepimut-S Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Wilms Tumor Protein include GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc, Otsuka Holdings Co Ltd, Sellas Life Sciences Group Ltd, Sumitomo Dainippon Pharma Co Ltd and Vaximm AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wilms Tumor Protein manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Wilms Tumor Protein Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs) Global Wilms Tumor Protein Market Segment Percentages, by Type, 2021 (%) Elatipepimut-S Galinpepimut-S GSK-2130579A INO-5401 OCV-501 Others Global Wilms Tumor Protein Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs) Global Wilms Tumor Protein Market Segment Percentages, by Application, 2021 (%) Adrenal Gland Cancer High-Grade Glioma Lung Cancer Peritoneal Cancer Others Global Wilms Tumor Protein Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs) Global Wilms Tumor Protein Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Wilms Tumor Protein revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Wilms Tumor Protein revenues share in global market, 2021 (%) Key companies Wilms Tumor Protein sales in global market, 2017-2022 (Estimated), (K Pcs) Key companies Wilms Tumor Protein sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: GlaxoSmithKline Plc Inovio Pharmaceuticals Inc Otsuka Holdings Co Ltd Sellas Life Sciences Group Ltd Sumitomo Dainippon Pharma Co Ltd Vaximm AG
1 Introduction to Research & Analysis Reports 1.1 Wilms Tumor Protein Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Wilms Tumor Protein Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Wilms Tumor Protein Overall Market Size 2.1 Global Wilms Tumor Protein Market Size: 2021 VS 2028 2.2 Global Wilms Tumor Protein Revenue, Prospects & Forecasts: 2017-2028 2.3 Global Wilms Tumor Protein Sales: 2017-2028 3 Company Landscape 3.1 Top Wilms Tumor Protein Players in Global Market 3.2 Top Global Wilms Tumor Protein Companies Ranked by Revenue 3.3 Global Wilms Tumor Protein Revenue by Companies 3.4 Global Wilms Tumor Protein Sales by Companies 3.5 Global Wilms Tumor Protein Price by Manufacturer (2017-2022) 3.6 Top 3 and Top 5 Wilms Tumor Protein Companies in Global Market, by Revenue in 2021 3.7 Global Manufacturers Wilms Tumor Protein Product Type 3.8 Tier 1, Tier 2 and Tier 3 Wilms Tumor Protein Players in Global Market 3.8.1 List of Global Tier 1 Wilms Tumor Protein Companies 3.8.2 List of Global Tier 2 and Tier 3 Wilms Tumor Protein Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Wilms Tumor Protein Market Size Markets, 2021 & 2028 4.1.2 Elatipepimut-S 4.1.3 Galinpepimut-S 4.1.4 GSK-2130579A 4.1.5 INO-5401 4.1.6 OCV-501 4.1.7 Others 4.2 By Type - Global Wilms Tumor Protein Revenue & Forecasts 4.2.1 By Type - Global Wilms Tumor Protein Revenue, 2017-2022 4.2.2 By Type - Global Wilms Tumor Protein Revenue, 2023-2028 4.2.3 By Type - Global Wilms Tumor Protein Revenue Market Share, 2017-2028 4.3 By Type - Global Wilms Tumor Protein Sales & Forecasts 4.3.1 By Type - Global Wilms Tumor Protein Sales, 2017-2022 4.3.2 By Type - Global Wilms Tumor Protein Sales, 2023-2028 4.3.3 By Type - Global Wilms Tumor Protein Sales Market Share, 2017-2028 4.4 By Type - Global Wilms Tumor Protein Price (Manufacturers Selling Prices), 2017-2028 5 Sights By Application 5.1 Overview 5.1.1 By Application - Global Wilms Tumor Protein Market Size, 2021 & 2028 5.1.2 Adrenal Gland Cancer 5.1.3 High-Grade Glioma 5.1.4 Lung Cancer 5.1.5 Peritoneal Cancer 5.1.6 Others 5.2 By Application - Global Wilms Tumor Protein Revenue & Forecasts 5.2.1 By Application - Global Wilms Tumor Protein Revenue, 2017-2022 5.2.2 By Application - Global Wilms Tumor Protein Revenue, 2023-2028 5.2.3 By Application - Global Wilms Tumor Protein Revenue Market Share, 2017-2028 5.3 By Application - Global Wilms Tumor Protein Sales & Forecasts 5.3.1 By Application - Global Wilms Tumor Protein Sales, 2017-2022 5.3.2 By Application - Global Wilms Tumor Protein Sales, 2023-2028 5.3.3 By Application - Global Wilms Tumor Protein Sales Market Share, 2017-2028 5.4 By Application - Global Wilms Tumor Protein Price (Manufacturers Selling Prices), 2017-2028 6 Sights by Region 6.1 By Region - Global Wilms Tumor Protein Market Size, 2021 & 2028 6.2 By Region - Global Wilms Tumor Protein Revenue & Forecasts 6.2.1 By Region - Global Wilms Tumor Protein Revenue, 2017-2022 6.2.2 By Region - Global Wilms Tumor Protein Revenue, 2023-2028 6.2.3 By Region - Global Wilms Tumor Protein Revenue Market Share, 2017-2028 6.3 By Region - Global Wilms Tumor Protein Sales & Forecasts 6.3.1 By Region - Global Wilms Tumor Protein Sales, 2017-2022 6.3.2 By Region - Global Wilms Tumor Protein Sales, 2023-2028 6.3.3 By Region - Global Wilms Tumor Protein Sales Market Share, 2017-2028 6.4 North America 6.4.1 By Country - North America Wilms Tumor Protein Revenue, 2017-2028 6.4.2 By Country - North America Wilms Tumor Protein Sales, 2017-2028 6.4.3 US Wilms Tumor Protein Market Size, 2017-2028 6.4.4 Canada Wilms Tumor Protein Market Size, 2017-2028 6.4.5 Mexico Wilms Tumor Protein Market Size, 2017-2028 6.5 Europe 6.5.1 By Country - Europe Wilms Tumor Protein Revenue, 2017-2028 6.5.2 By Country - Europe Wilms Tumor Protein Sales, 2017-2028 6.5.3 Germany Wilms Tumor Protein Market Size, 2017-2028 6.5.4 France Wilms Tumor Protein Market Size, 2017-2028 6.5.5 U.K. Wilms Tumor Protein Market Size, 2017-2028 6.5.6 Italy Wilms Tumor Protein Market Size, 2017-2028 6.5.7 Russia Wilms Tumor Protein Market Size, 2017-2028 6.5.8 Nordic Countries Wilms Tumor Protein Market Size, 2017-2028 6.5.9 Benelux Wilms Tumor Protein Market Size, 2017-2028 6.6 Asia 6.6.1 By Region - Asia Wilms Tumor Protein Revenue, 2017-2028 6.6.2 By Region - Asia Wilms Tumor Protein Sales, 2017-2028 6.6.3 China Wilms Tumor Protein Market Size, 2017-2028 6.6.4 Japan Wilms Tumor Protein Market Size, 2017-2028 6.6.5 South Korea Wilms Tumor Protein Market Size, 2017-2028 6.6.6 Southeast Asia Wilms Tumor Protein Market Size, 2017-2028 6.6.7 India Wilms Tumor Protein Market Size, 2017-2028 6.7 South America 6.7.1 By Country - South America Wilms Tumor Protein Revenue, 2017-2028 6.7.2 By Country - South America Wilms Tumor Protein Sales, 2017-2028 6.7.3 Brazil Wilms Tumor Protein Market Size, 2017-2028 6.7.4 Argentina Wilms Tumor Protein Market Size, 2017-2028 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Wilms Tumor Protein Revenue, 2017-2028 6.8.2 By Country - Middle East & Africa Wilms Tumor Protein Sales, 2017-2028 6.8.3 Turkey Wilms Tumor Protein Market Size, 2017-2028 6.8.4 Israel Wilms Tumor Protein Market Size, 2017-2028 6.8.5 Saudi Arabia Wilms Tumor Protein Market Size, 2017-2028 6.8.6 UAE Wilms Tumor Protein Market Size, 2017-2028 7 Manufacturers & Brands Profiles 7.1 GlaxoSmithKline Plc 7.1.1 GlaxoSmithKline Plc Corporate Summary 7.1.2 GlaxoSmithKline Plc Business Overview 7.1.3 GlaxoSmithKline Plc Wilms Tumor Protein Major Product Offerings 7.1.4 GlaxoSmithKline Plc Wilms Tumor Protein Sales and Revenue in Global (2017-2022) 7.1.5 GlaxoSmithKline Plc Key News 7.2 Inovio Pharmaceuticals Inc 7.2.1 Inovio Pharmaceuticals Inc Corporate Summary 7.2.2 Inovio Pharmaceuticals Inc Business Overview 7.2.3 Inovio Pharmaceuticals Inc Wilms Tumor Protein Major Product Offerings 7.2.4 Inovio Pharmaceuticals Inc Wilms Tumor Protein Sales and Revenue in Global (2017-2022) 7.2.5 Inovio Pharmaceuticals Inc Key News 7.3 Otsuka Holdings Co Ltd 7.3.1 Otsuka Holdings Co Ltd Corporate Summary 7.3.2 Otsuka Holdings Co Ltd Business Overview 7.3.3 Otsuka Holdings Co Ltd Wilms Tumor Protein Major Product Offerings 7.3.4 Otsuka Holdings Co Ltd Wilms Tumor Protein Sales and Revenue in Global (2017-2022) 7.3.5 Otsuka Holdings Co Ltd Key News 7.4 Sellas Life Sciences Group Ltd 7.4.1 Sellas Life Sciences Group Ltd Corporate Summary 7.4.2 Sellas Life Sciences Group Ltd Business Overview 7.4.3 Sellas Life Sciences Group Ltd Wilms Tumor Protein Major Product Offerings 7.4.4 Sellas Life Sciences Group Ltd Wilms Tumor Protein Sales and Revenue in Global (2017-2022) 7.4.5 Sellas Life Sciences Group Ltd Key News 7.5 Sumitomo Dainippon Pharma Co Ltd 7.5.1 Sumitomo Dainippon Pharma Co Ltd Corporate Summary 7.5.2 Sumitomo Dainippon Pharma Co Ltd Business Overview 7.5.3 Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Major Product Offerings 7.5.4 Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Sales and Revenue in Global (2017-2022) 7.5.5 Sumitomo Dainippon Pharma Co Ltd Key News 7.6 Vaximm AG 7.6.1 Vaximm AG Corporate Summary 7.6.2 Vaximm AG Business Overview 7.6.3 Vaximm AG Wilms Tumor Protein Major Product Offerings 7.6.4 Vaximm AG Wilms Tumor Protein Sales and Revenue in Global (2017-2022) 7.6.5 Vaximm AG Key News 8 Global Wilms Tumor Protein Production Capacity, Analysis 8.1 Global Wilms Tumor Protein Production Capacity, 2017-2028 8.2 Wilms Tumor Protein Production Capacity of Key Manufacturers in Global Market 8.3 Global Wilms Tumor Protein Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Wilms Tumor Protein Supply Chain Analysis 10.1 Wilms Tumor Protein Industry Value Chain 10.2 Wilms Tumor Protein Upstream Market 10.3 Wilms Tumor Protein Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Wilms Tumor Protein Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com